Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lym phoma

被引：0
作者：
Muldoon, Leslie L. [1 ]
Lewin, Seth J. [1 ]
Dosa, Edit [1 ]
Pagel, Michael A. [1 ]
Doolittle, Nancy D. [1 ]
Neuwelt, Edward A. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5529
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5529
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease
    Berentsen, S
    Tjonnfjord, GE
    Brudevold, R
    Gjertsen, BT
    Langholm, R
    Lokkevik, E
    Sorbo, JH
    Ulvestad, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (01) : 79 - 83
  • [42] Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma
    Saesoo, S.
    Sathornsumetee, S.
    Anekwiang, P.
    Treetidnipa, C.
    Thuwajit, P.
    Bunthot, S.
    Maneeprakorn, W.
    Maurizi, L.
    Hofmann, H.
    Rungsardthong, Ruktanonchai Uracha
    Saengkrit, N.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 161 : 497 - 507
  • [43] Complement system in Anti-CD20 mAb therapy for cancer: A mini-review
    Gao, Yiwen
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [44] Different mechanisms are involved in different organ manifestation in SLE: Learning from treatments with rituximab (anti-CD20) therapy
    Tanaka, Yoshiya
    Tokunaga, Mikiko
    Nawata, Masao
    Iwata, Shigeru
    Nakano, Kazuhisa
    Yamaoka, Kunihiro
    Mima, Tom
    Nishimoto, Norihiro
    Saito, Kazuyoshi
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S568 - S569
  • [45] Treatment of primary Sjogren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
    Meiners, Petra M.
    Vissink, Arjan
    Kallenberg, Cees G. M.
    Kroese, Frans G. M.
    Bootsma, Hendrika
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (10) : 1381 - 1394
  • [46] Effects of combined therapy with gemcitabine and the anti-CD20 monoclonal antibody rituximab on human lymphoma cell lines.
    Joshi, I
    Jin, F
    Obasaju, C
    Smith, MR
    BLOOD, 2002, 100 (11) : 308B - 308B
  • [47] Quality of life in patients with B-cell lymphoma during maintenance therapy with the Anti-CD20 antibody rituximab
    Witzens-Harig, Mathias
    Heiss, Christiane
    Benner, Axel
    Hensel, Manfred
    Neben, Kai
    Dreger, Peter
    Kraemer, Alwin
    Ho, Anthony D.
    BLOOD, 2007, 110 (11) : 189B - 189B
  • [48] Quality of life in patients with Non-Hodgkins-Lymphoma during maintenance therapy with the anti-CD20 antibody rituximab
    Witzens-Harig, M.
    Reiz, M.
    Heiss, C.
    Benner, A.
    Hensel, M.
    Neben, K.
    Dreger, P.
    Kraemer, A.
    Ho, A. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 108
  • [49] Intraventricular Rituximab in Pediatric CD20-positive Refractory Primary Central Nervous System Lymphoma
    Wada-Shimosato, Yuko
    Ikeda, Junji
    Tsujimoto, Shin-ichi
    Sasaki, Koji
    Yanagimachi, Masakatsu
    Kajiwara, Ryosuke
    Shiba, Norio
    Murata, Hidetoshi
    Kawahara, Nobutaka
    Yamanaka, Shoji
    Tanoshima, Reo
    Ito, Shuichi
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (07) : 571 - 573
  • [50] Anti-CD20 therapy suppresses cortical pathology in a new rat model of cortical demyelination
    Haindl, M. T.
    Ucal, M.
    Klaus, B.
    Toegl, L.
    Dohrmanni, J.
    Adzemovic, M. Z.
    Enzinger, C.
    Hochmeister, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 380 - 380
12345